{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:05:09Z","timestamp":1794873909942,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"May Lam Research and Education Fund of The Primasia International Eye Research Institute (PIERI), School of Medicine, The Chinese University of Hong Kong"},{"name":"Shun Hing Education and Charity Fund"},{"name":"Bright Future Charitable Foundation Postgraduate Education Fund"},{"name":"Daniel & Co Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myopia is a global public health issue, necessitating effective control strategies. Defocus incorporated multiple segments (DIMS) and highly aspherical lenslet (HAL) spectacle lenses, as well as their combination with low-concentration atropine (0.01%), have been shown to control myopia effectively. However, direct comparisons among these regimens, DIMS, HAL, DIMSA (DIMS\u2009+\u2009atropine), and HALA (HAL\u2009+\u2009atropine), are lacking. In this real-world study, we compared their effectiveness in slowing myopia progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study included 347 children (694 eyes) aged 6\u201314\u00a0years who received one of the four interventions for at least 1\u00a0year. The primary outcome was the annual change in axial length (AL). The secondary outcome was the annual change in spherical equivalent refraction (SER). The treatment response was categorized as good, fair, or poor. Linear mixed models and generalized estimating equations were used for analysis, adjusting for covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After adjustment, annual axial elongation differed significantly among the groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), with marginal means of 0.23\u00a0mm (DIMS), 0.15\u00a0mm (HAL), 0.20\u00a0mm (DIMSA), and 0.12\u00a0mm (HALA). Post hoc comparisons revealed that both HAL and HALA were superior to DIMS (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and that HALA was superior to DIMSA (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022). Adding 0.01% atropine to either optical monotherapy did not provide a significant additional benefit in terms of mean AL or SER outcomes. Compared with DIMS, HALA significantly increased the odds of a good response for AL (OR\u2009=\u20094.34,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and SER (OR\u2009=\u20095.85,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), whereas this effect was not observed with DIMSA. Older age independently predicted better response (AL: OR\u2009=\u20091.46\/year; SER: OR\u2009=\u20091.26\/year; both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this non-randomized real-world comparison, HAL monotherapy was associated with slower SER progression, compared with DIMS. Although adding atropine did not improve mean outcomes, HALA showed the highest likelihood of a good response, suggesting a clinically meaningful benefit in response distribution. Although HALA did not consistently outperform HAL monotherapy across analyses, its advantage in achieving favourable individual responses supports its consideration for children requiring maximal intervention. These findings require confirmation in prospective randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40662-026-00487-z","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:02:04Z","timestamp":1778540524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of effectiveness of four myopia control interventions in Chinese children: a real-world retrospective study"],"prefix":"10.1186","volume":"13","author":[{"given":"Lizhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Ying","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S. C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"2","key":"487_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/bjo-2023-323887","volume":"109","author":"XJ Zhang","year":"2025","unstructured":"Zhang XJ, Zaabaar E, French AN, Tang FY, Kam KW, Tham CC, et al. Advances in myopia control strategies for children. Br J Ophthalmol. 2025;109(2):165\u201376.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"487_CR2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.7.6","volume":"66","author":"S Khanal","year":"2025","unstructured":"Khanal S, Tomiyama ES, Harrington SC. Childhood Myopia Part I: Contemporary Treatment Options. Invest Ophthalmol Vis Sci. 2025;66(7):6.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"487_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1125000","volume":"11","author":"C Lanca","year":"2023","unstructured":"Lanca C, Pang CP, Grzybowski A. Effectiveness of myopia control interventions: a systematic review of 12 randomized control trials published between 2019 and 2021. Front Public Health. 2023;11:1125000.","journal-title":"Front Public Health"},{"issue":"1","key":"487_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2024-003187","volume":"8","author":"A Lembo","year":"2024","unstructured":"Lembo A, Schiavetti I, Serafino M, Caputo R, Nucci P. Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles. BMJ Paediatr Open. 2024;8(1):e003187.","journal-title":"BMJ Paediatr Open"},{"issue":"1","key":"487_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2025-002142","volume":"10","author":"R Najji","year":"2025","unstructured":"Najji R, Bullimore M, Resnikoff S, Bron AM, Naudin M, Giraud C, et al. The real-world effectiveness of defocus incorporated multiple segments and highly aspherical lenslets on myopia control: a longitudinal study from the French myopia cohort. BMJ Open Ophthalmol. 2025;10(1):e002142.","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"487_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30157-2","volume":"13","author":"H Guo","year":"2023","unstructured":"Guo H, Li X, Zhang X, Wang H, Li J. Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control. Sci Rep. 2023;13(1):3048.","journal-title":"Sci Rep"},{"key":"487_CR7","first-page":"42","volume":"23","author":"L Chen","year":"2026","unstructured":"Chen L, Sun L, Liu J, Chen Y, Li J, Lin D, et al. Age modifies the comparative effectiveness of DIMS versus HAL spectacle lenses for myopia control: a real-world study. Transl Vis Sci Technol. 2026;23:42.","journal-title":"Transl Vis Sci Technol."},{"issue":"2","key":"487_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJW. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One. 2023;18(2):e0281816.","journal-title":"PLoS ONE"},{"issue":"9","key":"487_CR9","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","volume":"38","author":"T Tang","year":"2024","unstructured":"Tang T, Lu Y, Li X, Zhao H, Wang K, Li Y, et al. Comparison of the long-term effects of atropine in combination with orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Eye (Lond). 2024;38(9):1660\u20137.","journal-title":"Eye (Lond)"},{"issue":"1","key":"487_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25599-z","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang Z, Chen XF, He T, Tang Y, Du CX. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12(1):22311.","journal-title":"Sci Rep"},{"issue":"1","key":"487_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91089-7","volume":"15","author":"CY Lee","year":"2025","unstructured":"Lee CY, Yang SF, Chang YL, Huang JY, Lian IB, Chang CK. The effect of defocus incorporated multiple segment spectacles\u2019 lenses combined with different concentrations atropine for myopia control. Sci Rep. 2025;15(1):12356.","journal-title":"Sci Rep"},{"key":"487_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1074272","volume":"11","author":"M Yu","year":"2023","unstructured":"Yu M, Jiang L, Chen M. Effect of atropine 0.01% on myopia control in children aged 6\u201313 years during the 2022 lockdown in Shanghai. Front Public Health. 2023;11:1074272.","journal-title":"Front Public Health"},{"key":"487_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2025.104779","volume":"55","author":"G Hu","year":"2025","unstructured":"Hu G, Xu Z, Tao Z, Lv Z, Li W, Kang Z, et al. Therapeutic efficacy of highly aspherical lenslets combined with low-concentration atropine: A retrospective study. Photodiagnosis Photodyn Ther. 2025;55:104779.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"5","key":"487_CR14","first-page":"1280","volume":"55","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yang B, Li X, Ma W, Liu L, Yan N. [Efficacy of combining highly aspherical lenslets spectacles with 0.01% atropine eye drops in myopia control]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(5):1280\u20137.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"487_CR15","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.clae.2024.102317","volume":"48","author":"X Cao","year":"2025","unstructured":"Cao X, Guo Z, Wei Z, Ming H, Ma B, Zhao Y, et al. Effect of 001% atropine eye drops combined with different optical treatments to control low myopia in Chinese children. Cont Lens Anterior Eye. 2025;48(1):102317.","journal-title":"Cont Lens Anterior Eye."},{"issue":"07","key":"487_CR16","first-page":"481","volume":"27","author":"Optometry Group of Ophthalmology Branch of Chinese Medical A","year":"2025","unstructured":"Optometry Group of Ophthalmology Branch of Chinese Medical Association, Ophthalmology and Optometry Committee of Ophthalmologist Association of Chinese Doctor Association, Ophthalmology and Optometry Group of Ophthalmologic Committee of Chinese Non-Government Medical Institutions Association. [Expert consensus on myopia management white paper (2025)]. Zhonghua Yanshiguangxue Yu Shijuekexue Za Zhi. 2025;27(07):481\u20139.\u00a0doi: 10.3760\/cma.j.cn115909-20250401-00110.","journal-title":"Zhonghua Yanshiguangxue Yu Shijuekexue Za Zhi"},{"issue":"5","key":"487_CR17","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00417-022-05901-5","volume":"261","author":"J Chen","year":"2023","unstructured":"Chen J, Liu S, Zhu Z, Bulloch G, Naduvilath T, Wang J, et al. Axial length changes in progressive and non-progressive myopic children in China. Graefes Arch Clin Exp Ophthalmol. 2023;261(5):1493\u2013501.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"487_CR18","unstructured":"Optometry Group of Ophthalmology Branch of Chinese Medical Association, Ophthalmology and Optometry Committee of Ophthalmologist Association of Chinese Doctor Association. [Expert Consensus on Application of Low-Concentration Atropine Eye Drops in the Prevention and Control of Myopia in Children and Adolescents]. Zhonghua Yan Ke Za Zhi. 2024;26(9):641\u20138. doi: 10.3760\/cma.j.cn115909-20240802-00262."},{"key":"487_CR19","unstructured":"Optometry Group of Ophthalmology Branch of Chinese Medical Association, Ophthalmology and Optometry Committee of Ophthalmologist Association of Chinese Doctor Association. [Expert Consensus on the Application of Spectacle Related to Myopia Prevention and Control in Myopia Management (2023)]. 2023;25(11):801\u20138. doi: 10.3760\/cma.j.cn115909-20230920-00082."},{"key":"487_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-8491-2","volume-title":"Updates on myopia: a clinical perspective","author":"M Ang","year":"2020","unstructured":"Ang M, Wong TY. Updates on myopia: a clinical perspective. Springer Open; 2020."},{"issue":"8","key":"487_CR21","first-page":"573","volume":"61","author":"Society of Contact Lens Safety M","year":"2025","unstructured":"Society of Contact Lens Safety Monitoring & Vision, Health of Chinese Health Association, Western Optometry Expert Committee of Sichuan Optometry Society, Peiying Xie, Longqian Liu. [Chinese expert consensus on the efficacy evaluation and fitting of defocus multi-segment spectacle lenses designed for myopia control (2025)]. Zhonghua Yan Ke Za Zhi. 2025;61(8):573\u201380.\u00a0doi: 10.3760\/cma.j.cn112142-20241215-00583.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"487_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/opo.13098","volume":"43","author":"J Gantes-Nunez","year":"2023","unstructured":"Gantes-Nunez J, Jaskulski M, Lopez-Gil N, Kollbaum PS. Optical characterisation of two novel myopia control spectacle lenses. Ophthalmic Physiol Opt. 2023;43(3):388\u2013401.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"487_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/opo.12878","volume":"41","author":"Y Gao","year":"2021","unstructured":"Gao Y, Lim EW, Yang A, Drobe B, Bullimore MA. The impact of spectacle lenses for myopia control on visual functions. Ophthalmic Physiol Opt. 2021;41(6):1320\u201331.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"8","key":"487_CR24","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","volume":"128","author":"FF Li","year":"2021","unstructured":"Li FF, Zhang Y, Zhang X, Yip BHK, Tang SM, Kam KW, et al. Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-Concentration Atropine for Myopia Progression Study. Ophthalmology. 2021;128(8):1180\u20137.","journal-title":"Ophthalmology."},{"key":"487_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"487_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaophthalmol.2015.0471","volume":"133","author":"K Zadnik","year":"2015","unstructured":"Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, et al. Prediction of juvenile-onset myopia. JAMA Ophthalmol. 2015;133(6):683\u20139.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"487_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113\u201324.","journal-title":"Ophthalmology."},{"issue":"12","key":"487_CR28","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/jcph.2320","volume":"63","author":"H Sun","year":"2023","unstructured":"Sun H, Bu F, Xin X, Yan J. Incidence of adverse events induced by atropine in myopic children: a meta-analysis. J Clin Pharmacol. 2023;63(12):1377\u201386.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"487_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/opo.13277","volume":"44","author":"MA Sanchez-Tena","year":"2024","unstructured":"Sanchez-Tena MA, Ballesteros-Sanchez A, Martinez-Perez C, Alvarez-Peregrina C, De-Hita-Cantalejo C, Sanchez-Gonzalez MC, et al. Assessing the rebound phenomenon in different myopia control treatments: a systematic review. Ophthalmic Physiol Opt. 2024;44(2):270\u20139.","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00487-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-026-00487-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00487-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:02:05Z","timestamp":1778540525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40662-026-00487-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1186\/s40662-026-00487-z","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of the Second School of Clinical Medicine, Southern Medical University (Approval No: 2025-KY-171). The requirement for informed consent was waived owing to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}